Control of oocyte maturation

Oocyte maturation is a complex process involving nuclear and cytoplasmic maturation. The nuclear maturation is a chromosomal segregation and the cytoplasmic maturation involves the reorganization of the cytoplasmic organelles, mRNA transcription and storage of proteins to be used during fertilization and early embryo development. The mechanism of oocyte maturation in vivo and in vitro still are not totally understood. However it is generally accepted that the second messenger cyclic adenosine monophosphate (cAMP) plays a critical role in the maintenance of meiotic blockage of mammalian oocytes. A relative increase in the level of cAMP within the oocyte is essential for maintaining meiosis block, while a decrease in cAMP oocyte concentration allows the resumption of meiosis. The oocyte cAMP concentration is regulated by a balance of two types of enzymes: adenylate cyclase (AC) and phosphodiesterases (PDEs), which are responsible for the synthesis and degradation of cAMP, respectively. After being synthesized by AC in cumulus cells, cAMP are transferred to the oocyte through gap junctions. Thus, specific subtypes PDEs are able to inhibit or attenuate the spontaneous meiotic maturation of oocytes with PDE4 primarily involved in the metabolism of cAMP in granulosa cells and PDE3 in the oocyte. Although the immature oocytes can resume meiosis in vitro, after being removed from antral follicles, cytoplasmic maturation seems to occur asynchronously with nuclear maturation. Therefore, knowledge of the oocyte maturation process is fundamental for the development of methodologies to increase the success of in vitro embryo production and to develop treatments for various forms of infertility. This review will present current knowledge about the maintenance of the oocyte in prophase arrest, and the resumption of meiosis during oocyte maturation, focusing mainly on the changes that take place in the oocyte.

Control of oocyte maturation

Oocyte maturation is a complex process involving nuclear and cytoplasmic maturation. The nuclear maturation is a chromosomal segregation and the cytoplasmic maturation involves the reorganization of the cytoplasmic organelles, mRNA transcription and storage of proteins to be used during fertilization and early embryo development. The mechanism of oocyte maturation in vivo and in vitro still are not totally understood. However it is generally accepted that the second messenger cyclic adenosine monophosphate (cAMP) plays a critical role in the maintenance of meiotic blockage of mammalian oocytes. A relative increase in the level of cAMP within the oocyte is essential for maintaining meiosis block, while a decrease in cAMP oocyte concentration allows the resumption of meiosis. The oocyte cAMP concentration is regulated by a balance of two types of enzymes: adenylate cyclase (AC) and phosphodiesterases (PDEs), which are responsible for the synthesis and degradation of cAMP, respectively. After being synthesized by AC in cumulus cells, cAMP are transferred to the oocyte through gap junctions. Thus, specific subtypes PDEs are able to inhibit or attenuate the spontaneous meiotic maturation of oocytes with PDE4 primarily involved in the metabolism of cAMP in granulosa cells and PDE3 in the oocyte. Although the immature oocytes can resume meiosis in vitro, after being removed from antral follicles, cytoplasmic maturation seems to occur asynchronously with nuclear maturation. Therefore, knowledge of the oocyte maturation process is fundamental for the development of methodologies to increase the success of in vitro embryo production and to develop treatments for various forms of infertility. This review will present current knowledge about the maintenance of the oocyte in prophase arrest, and the resumption of meiosis during oocyte maturation, focusing mainly on the changes that take place in the oocyte. (AU)

Controle molecular do acúmulo, tradução e degradação de mRNA em oócitos e embriões / Molecular control of accumulation, translation and degradation of mRNA in oocytes and embryos

A competência oocitária para suportar os posteriores estágios do desenvolvimento depende não somenteda correta segregação cromossômica e de transformações citoesqueléticas, mas, principalmente, da adequadatranscrição e estoque de mRNAs cruciais ao desenvolvimento e à viabilidade celular. Com a retomada dameiose, no entanto, embora o oócito mantenha a capacidade de tradução gênica e de síntese proteica, suaatividade transcricional é interrompida, sendo restabelecida apenas com a ativação do genoma embrionário.Deste modo, todo mRNA materno mobilizado durante maturação, expansão do cumulus, fertilização eembriogênese inicial deve ser sintetizado e estocado, em sua forma traducionalmente inativa, nos oócitosmantidos no estágio diplóteno da prófase I. Complexos mecanismos regulatórios, os quais envolvem apoliadenilação e a desadenilação do mRNA, estão implicados no processo de ativação e silenciamento tantotranscricional quanto traducional. Assim, dada à relevância do tema, esta revisão se propõe a abordar osprincipais eventos moleculares envolvidos no controle da expressão, do estoque, da tradução e da degradação detranscritos maternos imprescindíveis ao desenvolvimento oocitário e embrionário.(AU)

The oocyte competence to support the later stages of development depends not only on correctchromosome segregation and cytoskeletal changes, but mainly, the proper transcription and storage of mRNAscritical to the cellular development and viability. However, with the resumption of meiosis, although the oocytekept the ability of gene translation and protein synthesis, its transcriptional activity is interrupted and restoredonly with embryonic genome activation. Thus, all maternal mRNA mobilized during maturation, cumulusexpansion, fertilization and early embryogenesis must be synthesized and stored, in its translationally inactiveform, in oocytes kept in the diplotene stage of prophase I. Complex regulatory mechanisms which involvedeadenylation and polyadenylation of mRNA are involved in this process of activation and silencing astranscriptional as translational. So, due to the importance of the topic, this review proposes to discuss the mainmolecular events involved in the control of expression, storage, translation and degradation of maternaltranscript essential to the oocyte and embryo development.(AU)

Controle molecular do acúmulo, tradução e degradação de mRNA em oócitos e embriões / Molecular control of accumulation, translation and degradation of mRNA in oocytes and embryos

A competência oocitária para suportar os posteriores estágios do desenvolvimento depende não somenteda correta segregação cromossômica e de transformações citoesqueléticas, mas, principalmente, da adequadatranscrição e estoque de mRNAs cruciais ao desenvolvimento e à viabilidade celular. Com a retomada dameiose, no entanto, embora o oócito mantenha a capacidade de tradução gênica e de síntese proteica, suaatividade transcricional é interrompida, sendo restabelecida apenas com a ativação do genoma embrionário.Deste modo, todo mRNA materno mobilizado durante maturação, expansão do cumulus, fertilização eembriogênese inicial deve ser sintetizado e estocado, em sua forma traducionalmente inativa, nos oócitosmantidos no estágio diplóteno da prófase I. Complexos mecanismos regulatórios, os quais envolvem apoliadenilação e a desadenilação do mRNA, estão implicados no processo de ativação e silenciamento tantotranscricional quanto traducional. Assim, dada à relevância do tema, esta revisão se propõe a abordar osprincipais eventos moleculares envolvidos no controle da expressão, do estoque, da tradução e da degradação detranscritos maternos imprescindíveis ao desenvolvimento oocitário e embrionário.

The oocyte competence to support the later stages of development depends not only on correctchromosome segregation and cytoskeletal changes, but mainly, the proper transcription and storage of mRNAscritical to the cellular development and viability. However, with the resumption of meiosis, although the oocytekept the ability of gene translation and protein synthesis, its transcriptional activity is interrupted and restoredonly with embryonic genome activation. Thus, all maternal mRNA mobilized during maturation, cumulusexpansion, fertilization and early embryogenesis must be synthesized and stored, in its translationally inactiveform, in oocytes kept in the diplotene stage of prophase I. Complex regulatory mechanisms which involvedeadenylation and polyadenylation of mRNA are involved in this process of activation and silencing astranscriptional as translational. So, due to the importance of the topic, this review proposes to discuss the mainmolecular events involved in the control of expression, storage, translation and degradation of maternaltranscript essential to the oocyte and embryo development.

Avaliação da migração das células progenitoras após terapia da tendinite equina / Migration evaluation of progenitor cells after treatment of equine tendinitis

A terapia celular vem sendo utilizada com resultados promissores no tratamento da tendinite equina, entretanto ainda existem dúvidas quanto à persistência e ao comportamento dessas células quando implantadas no local da lesão, e quanto à sua migração para outros focos inflamatórios. O objetivo deste estudo foi avaliar a marcação das células-tronco mesenquimais (CTMs) com nanocristal antes e após o implante em lesões tendíneas experimentais do tendão flexor digital superficial (TFDS) de equinos, bem como observar a possibilidade de migração das CTMs marcadas para outro foco de lesão, o membro contralateral do mesmo animal. Para isso, foi realizada a indução de lesão experimental no TFDS em ambos os membros torácicos de cinco equinos e, após sete dias, foram implantadas as CTMs autólogas marcadas com o nanocristal Qtracker 655 em um dos membros dos animais. Após sete dias do implante, foi realizada a biópsia tendínea para posterior avaliação histopatológica, utilizando-se microscopia com fluorescência. Também foi realizado o teste de viabilidade celular antes e após a incubação com o nanocristal. As CTMs marcadas e injetadas no tecido tendíneo mantiveram sua fluorescência sete dias após seu implante, e não ocorreu migração para o membro contralateral. O uso do nanocristal para a marcação das CTMs derivadas da medula óssea equina mostrou-se efetivo pelo fato de essa nanopartícula não ter alterado a viabilidade celular e por ela ter permanecido ativa durante o período implantado.(AU)

Cell therapy has been used with promising results in the treatment of equine tendinitis. However, there are still doubts about the persistence and behavior of these cells implanted in the injured tissue and their migration to other inflamed sites. The aim of this study was to evaluate the labeling of mesenchymal stem cells (MSCs) with nanocrystals before and after implantation in experimental tendinitis of the superficial digital flexor tendon (SDFT) of horses, observing the migration possibility of MSCs marked to another lesion, performed on the contralateral limb of the same animal. An experimental lesion was induced in SDFT in both forelimbs of five horses, and after seven days autologous MSCs labeled with Qtracker(r) 655 were implanted in one member of the animals. Tendon biopsy was performed for subsequent histopathological evaluation using fluorescence microscopy seven days after the implant. Cell viability test was also performed before and after incubation with the cell labeling kit. MSCs labeled and injected into the tendon tissue maintained their fluorescence seven days after their implantation and there was no migration to the contralateral limb. The use of nanocrystals for labeling MSCs was effective because it does not alter cell viability and remains active during the experimental period.(AU)

Peculiaridades da coleta de oócitos para produção in vitro de embriões ovinos / Peculiarities of oocyte harvesting for in vitro production of sheep embryos

A expansão da ovinocultura brasileira impulsionou o desenvolvimento de novas biotécnicas de reprodução assistida visando ao aumento dos índices produtivos em concomitância com o acelerado progresso genético. Neste contexto, a produção in vitro de embriões (PIV) ovinos se intensificou, devido à possibilidade de otimização das fêmeas doadoras de oócitos e de incremento da quantidade de embriões produzidos. Entre os vários fatores implicados no sucesso dessa biotecnologia, a qualidade dos complexos cumulus-oophorus (COCs), caracterizada, principalmente, pela presença das células do cumulus, é considerada crucial. Deste modo, é imprescindível a ampliação do conhecimento referente aos diferentes métodos de coleta dos COCs e suas peculiaridades, visando a futuros aperfeiçoamentos biotecnológicos.(AU)

The expansion of Brazilian sheep rearing promoted the development of new biotechnologies of assisted reproduction in order to increase the production indices concomitantly with accelerated genetic progress. In this context, the in vitro production (IVP) of sheep embryos has intensified due to the possibility of optimization of the female oocytes donor and increase the number of embryos produced. Among the various factors involved in the success of this biotechnology, the cumulus-oophorus complexes (COCs) quality, characterized, mainly, by the presence of cumulus cells, is considered crucial. Thus, it is essential to increase the knowledge on the different methods of collection of COCs and their peculiarities, aiming for future biotechnological improvements. (AU)

Peculiaridades da coleta de oócitos para produção in vitro de embriões ovinos / Peculiarities of oocyte harvesting for in vitro production of sheep embryos

A expansão da ovinocultura brasileira impulsionou o desenvolvimento de novas biotécnicas de reprodução assistida visando ao aumento dos índices produtivos em concomitância com o acelerado progresso genético. Neste contexto, a produção in vitro de embriões (PIV) ovinos se intensificou, devido à possibilidade de otimização das fêmeas doadoras de oócitos e de incremento da quantidade de embriões produzidos. Entre os vários fatores implicados no sucesso dessa biotecnologia, a qualidade dos complexos cumulus-oophorus (COCs), caracterizada, principalmente, pela presença das células do cumulus, é considerada crucial. Deste modo, é imprescindível a ampliação do conhecimento referente aos diferentes métodos de coleta dos COCs e suas peculiaridades, visando a futuros aperfeiçoamentos biotecnológicos.

The expansion of Brazilian sheep rearing promoted the development of new biotechnologies of assisted reproduction in order to increase the production indices concomitantly with accelerated genetic progress. In this context, the in vitro production (IVP) of sheep embryos has intensified due to the possibility of optimization of the female oocytes donor and increase the number of embryos produced. Among the various factors involved in the success of this biotechnology, the cumulus-oophorus complexes (COCs) quality, characterized, mainly, by the presence of cumulus cells, is considered crucial. Thus, it is essential to increase the knowledge on the different methods of collection of COCs and their peculiarities, aiming for future biotechnological improvements.

In vitro production of bovine embryos using Sigma antioxidant supplement®, tocopherol and L-ascorbic acid

This study tested the effect of Sigma antioxidant supplement®, α-tocopherol (vitamin E) and L-ascorbic acid (vitamin C) in the culture medium of bovine embryos. In experiment 1, in vitro produced bovine zygotes were cultured in Human Tubal Fluid (HTF): Eagles Basic Medium (BME) with: Group 1 50 µm vitamin C; Group 2 200 µm vitamin E; Group 3 25 µm vitamin C and 100 µm vitamin E; Group 4 1 µl/ml Sigma antioxidant supplement®; and the Control group HTF:BME only. In experiment 2, embryos were cultured in high or low oxygen tension with HTF:BME + Sigma antioxidant supplement® or in HTF:BME alone (Control). The data were analyzed using ANOVA followed by Tukeys test. The results of experiment 1 showed a negative effect (P < 0.05) of vitamin E on blastocyst production in Group 2 (19.7 ± 0.1%). This effect was reduced in Group 3 by the addition of vitamin C (26.1 ± 0.2%). The use of vitamin C alone (34.9 ± 0.3%) or the Sigma antioxidant supplement® (33.3 ± 0.7%) did not increase (P > 0.05) the number of blastocysts produced compared with the control group (30.1 ± 0.5%). During experiment 2, there was no effect (P > 0.05) from the culture medium or the O2 concentrations used, indicating that the reduction of the O2 concentration did not improve blastocyst production.(AU)

In vitro production of bovine embryos using Sigma antioxidant supplement®, tocopherol and L-ascorbic acid

This study tested the effect of Sigma antioxidant supplement®, α-tocopherol (vitamin E) and L-ascorbic acid (vitamin C) in the culture medium of bovine embryos. In experiment 1, in vitro produced bovine zygotes were cultured in Human Tubal Fluid (HTF): Eagle’s Basic Medium (BME) with: Group 1 – 50 µm vitamin C; Group 2 – 200 µm vitamin E; Group 3 – 25 µm vitamin C and 100 µm vitamin E; Group 4 – 1 µl/ml Sigma antioxidant supplement®; and the Control group – HTF:BME only. In experiment 2, embryos were cultured in high or low oxygen tension with HTF:BME + Sigma antioxidant supplement® or in HTF:BME alone (Control). The data were analyzed using ANOVA followed by Tukey’s test. The results of experiment 1 showed a negative effect (P 0.05) the number of blastocysts produced compared with the control group (30.1 ± 0.5%). During experiment 2, there was no effect (P > 0.05) from the culture medium or the O2 concentrations used, indicating that the reduction of the O2 concentration did not improve blastocyst production.